via Indiana University School of Medicine
A silicone device that can change skin tissue into blood vessels and nerve cells has advanced from prototype to standardized fabrication, meaning it can now be made in a consistent, reproducible way. As reported in Nature Protocols, this work, developed by researchers at the Indiana University School of Medicine, takes the device one step closer to potential use as a treatment for people with a variety of health concerns.
The technology, called tissue nanotransfection, is a non-invasive nanochip device that can reprogram tissue function by applying a harmless electric spark to deliver specific genes in a fraction of a second. In laboratory studies, the device successfully converted skin tissue into blood vessels to repair a badly injured leg. The technology is currently being used to reprogram tissue for different kinds of therapies, such as repairing brain damage caused by stroke or preventing and reversing nerve damage caused by diabetes.
“This report on how to exactly produce these tissue nanotransfection chips will enable other researchers to participate in this new development in regenerative medicine,” said Chandan Sen, director of the Indiana Center for Regenerative Medicine and Engineering, associate vice president for research and Distinguished Professor at the IU School of Medicine.
Sen also leads the regenerative medicine and engineering scientific pillar of the IU Precision Health Initiative and is lead author on the new publication.
“This small silicone chip enables nanotechnology that can change the function of living body parts,” he said. “For example, if someone’s blood vessels were damaged because of a traffic accident and they need blood supply, we can’t rely on the pre-existing blood vessel anymore because that is crushed, but we can convert the skin tissue into blood vessels and rescue the limb at risk.”
In the Nature Protocols report, researchers published engineering details about how the chip is manufactured.
Sen said this manufacturing information will lead to further development of the chip in hopes that it will someday be used clinically in many settings around the world.
“This is about the engineering and manufacturing of the chip,” he said. “The chip’s nanofabrication process typically takes five to six days and, with the help of this report, can be achieved by anyone skilled in the art.”
Sen said he hopes to seek FDA approval for the chip within a year. Once it receives FDA approval, the device could be used for clinical research in people, including patients in hospitals, health centers and emergency rooms, as well as in other emergency situations by first responders or the military.
The Latest on: Tissue reprogramming
- CSF1R inhibition could delay muscular dystrophy progressionon July 1, 2022 at 6:25 am
Investigators at University of British Columbia have reported the precise cellular populations responsible for the inability to regenerate muscle tissues in muscular dystrophy.
- Human urine-derived stem cells have robust regenerative potentialon June 28, 2022 at 10:06 am
The Wake Forest Institute for Regenerative Medicine (WFIRM) researchers, who were the first to identify that stem cells in human urine have potential for tissue regenerative effects, continue ...
- Cardiothoracic Surgery and Cardiovascular Biophysics Research Laboratoryon June 26, 2022 at 7:51 pm
These efforts draw upon a large multidisciplinary knowledgebase, applying the thinking, phenomena, techniques, and technology of cardiovascular biophysics, molecular biology, mechanobiology, cellular ...
- Skin in the game: a baseball player-turned-anti-aging guru pitches a technique to freeze and preserve cellson June 26, 2022 at 2:00 am
His baseline message: as we age, cells become less reliable and lose their ability to regenerate tissue. “I saw this firsthand, working in tissue engineering at University of Toronto and Mount Sinai ...
- Changed gene expression after heart surgery extends cardiomyocyte regenerationon June 24, 2022 at 2:05 pm
The ability to regenerate dead muscle tissue in mammalian hearts disappears just a few days after birth because the heart muscle cells, called cardiomyocytes, exit the cell cycle. In 2020 ...
- What are Ribosomopathies?on June 23, 2022 at 6:58 am
They are characterized by tissue-specific phenotypic abnormalities ... In addition, ribosomopathies show rewiring of the metabolism; this reprogramming of specific subsets of proteins that support ...
- Research shows a bacterial feeding frenzy in corn cropson June 23, 2022 at 5:59 am
Corn crops face a variety of bacterial threats but one species of bacteria, Pantoea stewartii, which causes Stewart’s wilt, takes that threat further than ...
- Enrichment of the Embryonic Stem Cell Reprogramming Factors Oct4, Nanog, Myc, and Sox2 in Benign and Malignant Vascular Tumorson June 22, 2022 at 5:00 pm
Methods: In this study, the expression levels of the embryonic stem cell reprogramming factors Oct4 ... on staining intensity and percentage of tissue positive for each antigen, and subsequently ...
- ‘Nanotransfection’ Turns Animal Skin into Blood Vessels and Brain Cellson June 20, 2022 at 5:00 pm
Researchers have developed tissue nanotransfection ... In experiments on mice, the technology restored blood flow to injured legs by reprogramming the animals' skin cells to become vascular cells.
- Stem Cells Fast Factson May 31, 2022 at 12:58 pm
Adult stem cells are already designated for a certain organ or tissue. Some adult stem cells ... embryonic stem cell from human skin cells by reprogramming human skin cells back to their embryonic ...
via Bing News
The Latest on: Tissue reprogramming
via Google News